CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline

Powered by SearchMedica

 
Publications
News
Conferences
Podcasts
CME
Classifieds
Supplements
For Patients
For Nurses
Cancer Management Handbook
 

Home » Cancer Management Handbook » Chapter 21

Cancer Management: A Multidisciplinary Approach, 12th Edition (2009).
Pages: 1  2  3  4  5  6  
Previous Next
Chapter 21 

Bone sarcomas

By Alan W. Yasko, MD, Warren Chow, MD, and Deborah Frassica, MD | March 9, 2010

Signs and symptoms

Local symptoms
Localized pain and swelling are the hallmark clinical features of bone sarcomas. The pain, which initially is insidious and transient, becomes progressively more severe and unremitting. Localized soft-tissue swelling, with or without associated warmth and erythema, may be present. A joint effusion may be observed, and range of motion of the adjacent joint may be limited and painful. Movement or weight-bearing of the involved extremity may exacerbate local symptoms.

Patients with tumors arising in the lower extremities can present with a painful limp. The neurovascular examination of the affected extremity is usually normal. Regional lymph nodes are rarely involved.

Pathologic fracture may also be a presenting sign, although a history of pain prior to fracture usually can be elicited.

Constitutional symptoms
These are rare in patients with bone sarcoma, but such symptoms as fever, malaise, and weight loss can be observed in those with Ewing's sarcoma.

Screening and diagnosis

Currently, there is no screening test for primary bone sarcomas. The diagnosis must be made by clinical and radiographic evaluations and confirmed by histopathologic analysis of biopsy-obtained tissue.

Physical examination
Physical examination should include an assessment of the local extent of the soft-tissue mass, if present, and its relationship to the adjacent joint.

Laboratory studies
A CBC may demonstrate anemia and/or leukocytosis associated with Ewing's sarcoma, but, in general, results of these studies fall within the normal range. Alkaline phosphatase and lactic dehydrogenase (LDH) levels may be elevated in patients with osteosarcoma or Ewing's sarcoma. An abnormal glucose tolerance test may be observed in patients with chondro-
sarcomas.

X-rays
Biplanar (anteroposterior and lateral) plain radiographs of the affected extremity provide critical information on the nature of the bone lesion. The specific site of involvement within the bone, the pattern and extent of bone destruction, type of periosteal changes, and the presence of matrix mineralization within the tumor, and of soft-tissue extension may be gleaned from plain films.

CT
Standard CT scans provide further delineation of many of these changes.

MRI
MRI is the imaging study of choice for evaluating the extent of an associated soft-tissue mass and the relationship of the tumor to the neurovascular structures, surrounding soft tissues, and the adjacent joint. The intramedullary extent of the tumor and presence of skip metastases within the bone are best demonstrated by MRI.

Bone scan
A bone scan is performed to screen for distant osseous metastases.

Chest radiographic studies
A plain film of the chest is required in any patient suspected of having a bone sarcoma. Once the diagnosis of malignancy has been established, a CT scan of the chest is a critical part of initial staging.

Biopsy
With few exceptions, a biopsy must be obtained to confirm the diagnosis. Tissue may be obtained by percutaneous (closed) or surgical (open) techniques. The biopsy should be performed by personnel expert in percutaneous biopsy techniques who are familiar with bone tumors and their treatment.

Biopsies performed at referring institutions have been reported to be associated with a higher incidence of misdiagnosis and complications, which may affect patient outcome. Optimally, the biopsy should be performed at the institution where definitive treatment will be given.

 

Pages: 1  2  3  4  5  6  
Previous Next
 

Add your own comment





 
Table of Contents

Chapter 1: Head and Neck Tumors

Chapter 2: Thyroid and Parathyroid Cancers

Chapter 3: Non-Small-Cell Lung Cancer

Chapter 4: Small-Cell Lung Cancer, Mesothelioma, and Thymoma

Chapter 5: Breast Cancer Overview

Chapter 6: Stages 0 and I breast cancer

Chapter 7: Stage II breast cancer

Chapter 8: Stages III and IV breast cancer

Chapter 9: Esophageal cancer

Chapter 10: Gastric cancer

Chapter 11: Pancreatic, neuroendocrine GI, and adrenal cancers

Chapter 12: Liver, gallbladder, and biliary tract cancers

Chapter 13: Colon, rectal, and anal cancers

Chapter 14: Prostate cancer

Chapter 15: Testicular cancer

Chapter 16: Urothelial and kidney cancers

Chapter 17: Cervical cancer

Chapter 18: Uterine corpus tumors

Chapter 19: Ovarian cancer

Chapter 20: Melanoma and other skin cancers

Chapter 21: Bone sarcomas

Chapter 22: Soft-tissue sarcomas

Chapter 23: Primary and metastatic brain tumors

Chapter 24: AIDS-related malignancies

Chapter 25: Carcinoma of an unknown primary site

Chapter 26: Hodgkin lymphoma

Chapter 27: Non-Hodgkin lymphoma

Chapter 28: Multiple myeloma and other plasma cell dyscrasias

Chapter 29: Acute leukemias

Chapter 30: Chronic myeloid leukemia

Chapter 31: Chronic lymphocytic leukemia

Chapter 32: Myelodysplastic syndromes

Chapter 33: Hematopoietic cell transplantation

Chapter 34: Pain management

Chapter 35: Management of nausea and vomiting

Chapter 36: Depression, anxiety, and delirium

Chapter 37: Fatigue and dyspnea

Chapter 38: Anorexia and cachexia

Chapter 39: Oncologic emergencies and paraneoplastic syndromes

Chapter 40: Infectious complications

Chapter 41: Fluid complications

Color atlas The ABCDEs of moles and melanomas

Color atlas 2: Skin lesions

Color atlas 3: Dermatologic toxicities associated with targeted therapies

Appendix 1: Response Evaluation Criteria and Performance Scales

Appendix 2: Cancer Information on the Internet

Appendix 3: Cancer Drugs and Indications Newly Approved by the US Food and Drug Administration

Appendix 4: Chemotherapeutic Agents Their Uses, Dosages, and Toxicites

 
News & News Analysis

Duration of tamoxifen use influences cancer risk in opposite breast
Oncology NEWS International,  October 15, 2009
Low-risk tumors exhibit high proliferation index
Oncology NEWS International,  October 15, 2009
Bayer Taps New CEO
Oncology NEWS International,  October 15, 2009
Adjuvant Rx yields minor benefit in less aggressive colon cancer
Oncology NEWS International,  October 15, 2009
Low expression of MSH2 protein predicts survival in NSCLC
Oncology NEWS International,  September 29, 2009
 
Most Popular Articles


Understanding and Treating Triple-Negative Breast Cancer

ONCOLOGY,  October 1, 2008

Your Patient With Melanoma: Staging Prognosis, and Treatment
ONCOLOGY Nurse Edition, August 5, 2009

Treatment of Metastatic Melanoma: An Overview
ONCOLOGY, May 13, 2009

Rising PSA in Nonmetastatic Prostate Cancer
ONCOLOGY, November 1, 2007
 

 

Order Your Copy!

 


 



Related Articles
 

Addressing Bone Loss in the Cancer Survivor

Stereotactic Body Radiotherapy in the Management of Painful Bone Metastases

FDG-PET Predicts Prognosis in Primary Osteosarcoma

New Therapeutics for Soft-Tissue Sarcomas in Adults

PET Imaging: Update on Sarcomas

 

 

 

 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Bone Sarcomas
Evidence on Bone Sarcomas
Guidelines on Bone Sarcomas
Patient Education on Bone Sarcomas
Clinical Trials on Bone Sarcomas
Practical Articles on Bone Sarcomas
Research and Reviews on Bone Sarcomas
All "Bone Sarcomas" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Psychiatric Times | Physicians Practice | SearchMedica

© 1996 - 2010 UBM Medica LLC, a United Business Media company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement


 
ADDITIONAL ONLINE RESOURCES FROM UBM MEDICA
Featured Resources > Psychiatry Careers > Practice Management Conference > Today's Practice - Practice Management Resource > RSV Information > EHR Resources
CancerNetwork > Cancer diagnosis, treatment, and prevention > Podcasts for Oncologists > Cancer Patient Resources > Oncology Areas of Confusion > Oncology News > Cancer Management Handbook > Breast Cancer Resource > Bone Metastases > Chronic Myeloid Leukemia
Consultant Live > Diabetes Resources > Pediatric Asthma > Practical Clinical Advice > Medical Photoclinic > Diagnosing and Treating H1N1 flu (swine flu) > Primary Care Conference Reports > Community Acquired MRSA
Diagnostic Imaging > Medical Imaging News and Features > Medical Imaging and Radiology White Papers > Radiology Conference Reports > Radiology Special Reports > Radiology Net Seminars > Imaging Trends and Advances > RSNA 2009 Conference Coverage > Radiology Vendors
Psychiatric Times > Psychiatric News and Special Reports > APA Conference Report > Psychiatric Clinical Scales > Psychiatric Times Blog > Psychiatry Career Opportunities > DSM-5 > Major Depressive Disorder
Physicians Practice > Practice Management > EMR Software > Medical Practice Management Software > Medical Buyers Guide > Medical Coding > Practice Management Blog
SearchMedica > Professional Medical Search Engine > Medical Search Tips Newsletter > Medical Search News > Diabetes Research and Articles
Musculoskeletal Network > Muscle, Bone, Joint Medical Resources > Rheumatoid Arthritis Resource Center
The AIDS Reader > HIV News, Treatment, and Diagnosis for Medical Professionals
CME LLC > Continuing Medical Education > Psychiatry CME > Oncology CME > Practice Management CME > Primary Care CME > Psychiatric Congress > Performance Improvement CME > Treating the Whole Patient (TWP) — The Mind-Body Connection
More Resources > Consumer Healthcare Information > Patient and Caregiver Resource > Search drug information, interactions, images & diagnosis > Infectious Diseases > Respiratory Disease